AI-generated · cited to primary sources · not investment advice · How we research
Ugro Capital
Our verdict on Ugro Capital isn’t the consensus take — see where we landed, and the one risk the bull case glosses over.
See the verdict — free →Does management do what it says?
Portfolio yield increased from 17.3% in Q4'FY25 to 17.6% in Q2'FY26, a 30 bps increase within the first half of the year. (1 met, 1 exceeded, 2 in progress across 4 tracked commitments)
“So combination of 2, one is at an average yield of around 25%, which is a merchant lending business and emerging market LAP at an average going forward yield of 17.5% would incrementally increase the total yield on portfolio progressively by at least 200 basis points.”
The CRAR has further improved to 25.4% as of September 30, 2025. (2 exceeded, 1 revised, 2 in progress across 5 tracked commitments)
“Importantly, throughout this transition, the company expects to maintain a healthy capital adequacy with growth being funded largely through internal accruals, consistent with the balance sheet profile outlined in the presentation, leading to a non-incremental primary capital requirement.”
Management has backed away from the specific 4% ROA target, citing a shift in the business model away from high-contribution co-lending/direct assignment gains toward annuity interest income. (1 revised across 1 tracked commitment)
“So eventually, the ambition is to deliver a steady-state ROA of about 4% and an ROE of 16% to 18%. Currently, we are at about between 2% to 2.5%... So, in next about 2 years, that is where we want to be.”
Fund growth entirely through internal accruals with no incremental equity through FY29. — target: No incremental equity
“The fourth no incremental equity through FY29, growth funded entirely from internal accruals.”
The company has recalibrated disbursals to reduce liability requirements and lower future borrowing costs through tightened underwriting. — target: Lower cost of borrowing (+1 more commitment)
“we have recalibrated current year’s disbursals so that we can reduce our liability requirements leading to lower cost of borrowing in future. This has been done by adopting tightened underwriting”
See the full cited Management analysis of Ugro Capital
How durable is the business?
Capital adequacy has strengthened to 22.4% following successful rights and preferential issues, providing a larger buffer for growth and the Profectus Capital acquisition. (5 expanding)
“CAR improved to 21.2% (vs 20.8% in Dec-25), supporting the Feb-26 commitment of no incremental equity raise over the next three years.”
Net total income grew significantly by 31% year-on-year, reaching Rs. 216.5 crores, driven by a 31% increase in Assets Under Management (AUM). (5 expanding across 1 engine)
“Interest Income 415.2... Total Income 631.7”
The South region's dominance in the Emerging Market portfolio has increased from 44% to 48% of total EM AUM. (5 expanding across 1 engine)
“Other Income 61.9”
The physical footprint has expanded aggressively from 150 locations in FY24 to 309 locations as of June 2025, nearly doubling the reach to capture small-ticket loans. (5 expanding)
“In this journey, we have expanded our footprint from 150 locations in FY'24 to 309 locations as of June'25.”
The moat is strengthening with the launch of GRO Score 3.0, which now integrates GST data alongside Bureau and Banking data for 360-degree underwriting. (4 expanding, 1 shifted)
“Automated end-to-end underwriting process, backed by robust tech engine... Fully tech-backed decision making with no manual intervention”
See the full cited Business Model analysis of Ugro Capital
Where does growth come from?
The company is successfully shifting its AUM mix toward high-yield focus verticals. Emerging Market and Embedded Finance now constitute 31% of AUM, up from 25% in Q1'FY25. (5 accelerating across 5 signals)
“Shift portfolio to high-yield focus verticals... 85% of AUM by FY29 (currently 38%)”
The company is deepening its play in the $20 billion small retail credit gap through the MyShubhLife (MSL) platform, which is scaling rapidly with a steady monthly run rate. (2 accelerating across 2 signals)
“INR 2,280 Cr AUM across ~250k active customers - 6x growth in 15 months”
The company has successfully halted new disbursements in this segment, leading to a planned reduction in its share of the total portfolio. (1 reversing, 1 new trend, 3 steady across 5 signals, 2 leading indicators)
“Emerging Market LAP- AUM guidance... 20-25% CAGR in 3 years”
The company significantly bolstered its capital position through rights and preferential issues to fund the Profectus acquisition and future organic growth. (2 accelerating, 3 steady across 5 signals)
“We are standing at a healthy capital adequacy of 21.2%, which is up from 20.8% which we had shown last quarter... We will essentially not require incremental equity through FY29.”
The emerging market channel is showing strong productivity gains as branches mature, with older branches significantly outperforming newer ones in AUM per branch. (1 accelerating, 1 steady, 1 reversing across 3 signals)
“transition to be steady-state annuity-led, largely cash ROA of 3% to 3.5% by FY29, with negligible contribution from co-lending and direct assignment income.”
See the full cited Future Growth analysis of Ugro Capital
What could break the thesis?
The risk is intensifying in terms of regulatory uncertainty regarding co-lending guidelines, though the company plans to moderate off-book AUM to 35% post-acquisition. (1 intensifying, 4 easing)
“Off-book AUM at 38%, aligned with the annuity-led transition.”
The risk is INTENSIFYING as management admits their cost of borrowing is 150-200 basis points higher than peers due to high growth and lack of a parent company. (1 intensifying, 4 easing)
“Liability mix by lender profile: Banks 45%. Liability mix by product: Term Loan 54%.”
The company maintains a high level of capital to support growth, which is good for safety but can lower the Return on Equity (ROE) for shareholders if not deployed efficiently. [REGULATORY]
“CAR improved to 21.2% (vs 20.8% in Dec-25), supporting the Feb-26 commitment of no incremental equity raise over the next three years.”
The company maintains a high level of debt relative to its equity. While currently within regulatory limits, high leverage means any significant spike in bad loans could more quickly erode the company's net worth. [BALANCE_SHEET]
“Our net worth stands at INR 2,906 crores with a very healthy leverage of 3.7x... standing at a healthy capital adequacy of 21.2%.”
Management explicitly acknowledges stress in the unsecured portfolio due to over-leveraging in the market, leading to a significant reduction in disbursements for this segment. (1 intensifying, 1 easing)
“Unsecured portfolio has witnessed some stress on account of over leveraging; we have tightened our underwriting and have curtailed disbursements”
See the full cited Risk analysis of Ugro Capital
Ugro Capital analysis by filing period
Read the full thesis on Ugro Capital
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.